Universal-Beteiligungs- und Servicegesellschaft
CPRX

Universal-Beteiligungs- und Servicegesellschaft’s Catalyst Pharmaceutical CPRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Sell
73,737
-68,624
-48% -$2.03M ﹤0.01% 1238
2026
Q1 		$3.52M Sell
142,361
-25,402
-15% -$605K 0.01% 1024
2025
Q4 		$3.91M Buy
167,763
+38,695
+30% +$862K 0.01% 999
2025
Q3 		$2.54M Sell
129,068
-16,594
-11% -$341K ﹤0.01% 1179
2025
Q2 		$3.16M Sell
145,662
-25,174
-15% -$594K 0.01% 1014
2025
Q1 		$4.14M Sell
170,836
-8,014
-4% -$180K 0.01% 878
2024
Q4 		$3.73M Buy
+178,850
New +$3.84M 0.01% 781

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CPRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Catalyst Pharmaceutical (CPRX) stake by 48% in Q2 2026, selling an estimated $2.03M and leaving 73,737 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CPRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.14M in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 73,737 shares of Catalyst Pharmaceutical worth $2.32M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 68,624 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.03M.
  • Catalyst Pharmaceutical made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1238 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Catalyst Pharmaceutical position peaked at $4.14M in Q1 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.